Skip to main content
. 2018 Jul 27;16(3):416–425. doi: 10.5217/ir.2018.16.3.416

Table 6. A Univariate Analysis of Laboratory Data between IBD Inpatients with and without VTE.

VTE group (n=24) Non-VTE group (n=316) P-value
White blood cells (/μL) 6,090 (1,850-14,790) 5,030 (1,840-21,060) NSa
Platelet (104/μL) 26.4 (9.2–68.8) 28.1 (6.3–80.7) NSa
Serum albumin (g/dL) 3.0 (2.2–4.0) 3.6 (1.6–5.3) 0.0002a
Serum albumin ≤3.0 g/dL 16 (66.6) 68 (21.5) <0.0001b
CRP (mg/dL) 1.26 (0.1–16.9) 0.53 (0.1–39.1) 0.0260a
CRP ≥1.0 mg/dL 16 (66.6) 106 (33.5) 0.0150b
BUN (mg/dL) 10 (5–24) 10 (2–12) NSa
Total cholesterol (mg/dL) 102 (40–259) 85 (24–357) NSa
Triglyceride (mg/dL) 123 (84–189) 128 (51–258) NSa
PT-INR 1.15 (0.92–1.54) 1.14 (0.85–2.77) NSa
aPTT (s) 32.3 (21.7–46.4) 31.0 (23.2–52.7) NSa
Fibrinogen (mg/dL) 406.5 (183–546) 358 (286–827) NSa
D-dimer (ng/μL) 2.01 (0.09–53.39) 0.81 (0.04–13.7) 0.0022a
D-dimer ≥1.5 ng/μL 11 (45.8) 58 (18.3) 0.0010b
Anti-thrombin III (%) 91 (63–133) 94 (59–139) NSa

Values are presented as median (range) or number (%).

aMann-Whitney U-test.

bChi-square test.

VTE, venous thromboembolism.